These facts, as well as the evidence of overexpression of ADAM10 immature form in CRC, provide further insights into ADAM10 quality control governing ADAM10 trafficking along the secretory pathway with respect to ADAM10 dysregulation in cancer and in tissue homeostasis in general. This evidence concerns the gene ADAM10 and cancer.